One of the paintings from Gilead's latest campaign making AI art to help MBC patients be 'seen and heard.'

February 3, 2023 02:07 PM EST

Gilead combines artificial intelligence and art to draw attention and hope to MBC

Beth Snyder Bulik

Senior Editor

What if you could “see” the emotions and feelings of people living with metastatic breast cancer? That’s what Gilead Sciences’ agency VMLY&R Health did last …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Gilead combines artificial intelligence and art to draw attention and hope to MBC

Beth Snyder Bulik

Senior Editor

Sign up to read this article for free.

Uro-Oncology Business Manager

ImmunityBio, Inc.

Remote

New fund will pressure flailing biotechs, as investor frustration boils over

Akeso shares new data suggesting it can beat Keytruda on survival, wins China approval

Caribou lays off 32% of staff, cuts lupus cell therapy program before first patient

Merck KGaA closes in on SpringWorks deal at $3.5B price point

AbbVie commits $10B to expand US footprint with the threat of tariffs ahead

ADSTILADRIN® (nadofaragene firadenovec-vncg) – A Growing Body of Clinical Data and Real-World Evidence

Gilead com­bines ar­ti­fi­cial in­tel­li­gence and art to draw at­ten­tion and hope to MBC

Senior Editor

Sign up to read this article for free.

ImmunityBio, Inc.

Remote

Gilead combines artificial intelligence and art to draw attention and hope to MBC